[EN] THERAPEUTIC RADIOLABELLED CONJUGATES AND THEIR USE IN THERAPY<br/>[FR] CONJUGUÉS THÉRAPEUTIQUES RADIOMARQUÉS ET LEUR UTILISATION EN THÉRAPIE
申请人:CENTENARY INST OF CANCER MEDICINE AND CELL BIOLOGY
公开号:WO2022077068A1
公开(公告)日:2022-04-21
The invention relates to compounds according to Formula (I) wherein A is –As(OH)2or an arsenoxide equivalent group; each of R1, R2, R3and R4is independently selected from H, X, OH, NH2, CO, SCN, -CH2NH, -NHCOCH3, -NHCOCH2X or NO, and X is a halogen; R5is –NHCH2COOH, OH or OR6, wherein R6 is a C1-5straight or branched alkyl group; and Z is a therapeutic radioisotope, or a pharmaceutically acceptable salt, ester, prodrug or solvate thereof, uses of said compounds, and methods of preparing said compounds. The invention also relates to therapeutic methods utilizing said compounds. The invention further relates to processes for preparing compounds according to Formula (I) wherein Z is a radioisotope.
本发明涉及公式(I)的化合物,其中A为-As(OH)2或砷氧化物等效基团;R1、R2、R3和R4中的每一个独立选择自H、X、OH、NH2、CO、SCN、-CH2NH、-NHCOCH3、-NHCOCH2X或NO,其中X为卤素;R5为-NHCH2COOH、OH或OR6,其中R6为C1-5直链或支链烷基;以及Z为治疗性放射性同位素或其药学上可接受的盐、酯、前药或溶剂化物,所述化合物的用途以及制备所述化合物的方法。本发明还涉及利用所述化合物的治疗方法。本发明还涉及制备公式(I)中Z为放射性同位素的化合物的方法。